A new smart phone app and web portal to help oesophageal cancer patients and their carers understand and manage their journey better has been launched today by UCL, University College London Hospital (UCLH) and digital health company, Living With.
The personalised service, which is being piloted by the NHS in London, will allow clinical nurse specialists to have more time to monitor patients’ progress, provide relevant information and improve the care they can offer.
Oesophageal (Gullet) Cancer is the 4th largest cause of cancer death in the UK. It has one of the highest death rates of any cancer. In London a new care pathway has been established for people with oesophageal cancer living in the north, central and east London Cancer Alliance. Surgery is performed by a single ‘high volume’ specialist centre based at University College Hospital (UCH), with supportive care delivered by local hospitals.
This new pathway has shown to have better outcomes; however, it can cause problems for patients and health care staff, that the app and web portal has been designed to address. Patients often have their treatment spread between several different hospitals, which can be confusing and lead to missed appointments. It can also create more work for the Cancer Nurse Specialists (CNS), who provide expert support to cancer patients, as they need to organise treatments at different hospitals. This means they have less time to support patients’ physical, emotional, spiritual and social needs, leading to a worse patient experience.
The pilot running in Barnet Hospital aims to demonstrate that patients can be supported better and that the overall CNS workload can be reduced, enabling CNSs to focus more of their expertise on patients with the most needs. The new app and web portal does this by making it easier for CNSs to connect to, monitor, share information and improve the timeliness of their interventions with their patients. In turn patients receive accurate, reliable and easily comprehensible health information conveniently, privately, and at exactly the time they need it in relation to their specific pathway.
“I have used it everyday and find it all and more than I wished for,” said Lizzie Lloyd-Dehler, cancer survivor, who is the Patient and Public Involvement (PPI) representative
“After 18 months of careful design and development in collaboration with a wide range of multi-disciplinary stakeholders from UCL, UCLH and Macmillan including substantive input from patients and healthcare professionals, it’s great to see Living With Oesophageal Cancer going live in a hospital. This is the 5th product on our condition management platform now in the NHS and we are looking forward to seeing the results of the pilot.” Chris Robson, CEO of Living With, commented.
Professor Elizabeth Murray, Head of the Research Department of Primary Care and Population Health and Co-Director, eHealth Unit, UCL said “This is an exciting project, driven by cancer clinicians and patients, which has the potential to improve patient health outcomes and experience while reducing CNS workload and saving money for the NHS.”
Professor Muntzer Mughal, Honorary Clinical Professor and Consultant UGI Surgeon, UCLH: “This is an exciting project. The product will allow patients to access information and advice tailored to their condition and access to the CNS through the App. The App will also enable the CNS and clinicians to track the progress of their patients and to interact with them with advice and information and reminders about tests and appointments.
About Living With:
Living With is an award-winning digital health company and developers of the top paid medical app in the UK, Squeezy. The Living With condition management platform enables clinicians to connect to their patients and monitor their conditions remotely while saving costs and improving outcomes.
The Living With platform currently has five live products; Squeezy, the UK’s top paid medical app; Living With Pelvic Health, Living With Rheumatoid Arthritis, Living With Pregnancy Pain and Living With Oesophageal Cancer. The products are live across seventeen NHS trusts and ten private clinics. There are five further products in development.
For more information visit: https://livingwith.health/
About UCL – London’s Global University
UCL is a diverse community with the freedom to challenge and think differently.
Our community of more than 41,500 students from 150 countries and over 12,500 staff pursues academic excellence, breaks boundaries and makes a positive impact on real world problems.
We are consistently ranked among the top 10 universities in the world and are one of only a handful of institutions rated as having the strongest academic reputation and the broadest research impact.
We have a progressive and integrated approach to our teaching and research – championing innovation, creativity and cross-disciplinary working. We teach our students how to think, not what to think, and see them as partners, collaborators and contributors.
For almost 200 years, we are proud to have opened higher education to students from a wide range of backgrounds and to change the way we create and share knowledge.
We were the first in England to welcome women to university education and that courageous attitude and disruptive spirit is still alive today. We are UCL.